Atara Biotherapeutics, Inc. (ATRA) Price Prediction & ForecastATRAAtara Biotherapeutics, Inc.

Alphio's ATRA stock price prediction model matches the current Atara Biotherapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.95 (-0.16%). The 1-week path is $7.85 (-1.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Atara Biotherapeutics is currently not a strong buy due to mixed signals. The current price is $8.59, which is significantly below its 52-week high of $19.14, indicating a potential for recovery. However, the RSI is at 47.79, suggesting the stock is neither overbought nor oversold. The forward P/E ratio is 15.15, which is reasonable, but the company has a negative net income margin of -767.30% in Q2 2026, indicating ongoing financial struggles. The recent insider selling has increased by 29504.54%, which raises concerns about insider confidence. Therefore, while there are some positive catalysts, such as potential FDA approval, the risks outweigh the benefits at this time.

Atara Biotherapeutics, Inc. (ATRA) last closed at $7.96, losing -4.90%. These facts feed the 1-day and 1-week ATRA price prediction above.